
CAR T cells target senescent cells, improve healthspan in mice
CAR T cell therapy pioneered at Memorial Sloan Kettering Cancer Center (MSK) is showing promise in treating age-related diseases, such as metabolic decline, and could extend lifespan. The approach, using engineered immune cells to target senescent (nondividing) cells, has potential for diseases like chronic obstructive pulmonary disease (COPD), nonalcoholic steatohepatitis (NASH), osteoarthritis, metabolic syndrome, and…